Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Cutaneous Expression of Prostaglandin F2-alpha (PGF2α) in Vitiligo Patients: a Case-control Study.

NCT03755830 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT03755830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03755830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Cutaneous Expression of Prostaglandin F2-alpha (PGF2α) in Vitiligo Patients: a Case-control Study.
Lead sponsor
Cairo University
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2018
Completion date
July 31, 2019
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

vitiligo